Related Experiment Videos
Primary hyperoxaluria type-1: an unprecedented presentation at birth.
Anjali Patwardhan1, Cathy Higgins
1Neonatal Intensive Care Unit, New Cross-Hospital, Royal Wolverhampton NHS Trust, Wolverhampton, England, U.K. doctoranjali@hotmail.com
Indian Pediatrics
|March 16, 2005
Summary
This case report details a male infant diagnosed with primary hyperoxaluria type-1 (PH1) presenting with severe symptoms at birth. Early intervention with specific treatments led to clinical improvement, highlighting the importance of prompt diagnosis and management.
Area of Science:
- Pediatric Nephrology
- Neonatology
- Medical Genetics
Background:
- Primary hyperoxaluria type-1 (PH1) is a rare genetic metabolic disorder.
- It leads to excessive oxalate production and deposition in the kidneys and other organs.
- Early diagnosis and management are crucial to prevent severe complications.
Observation:
- A male neonate presented with cyanotic episodes, hypotonia, tachypnea, and tachycardia within hours of birth.
- Clinical evaluation revealed renal calcinosis.
- Cranial CT scan showed a middle cerebral arterial infarct with ventricular enlargement and a porencephalic cyst.
Findings:
- The infant was diagnosed with primary hyperoxaluria type-1.
- The patient showed clinical improvement following treatment with diuretics, hydration, pyridoxine, and Albright solution.
- This suggests a potential therapeutic response to these interventions in PH1.
Implications:
- This case underscores the critical need for early recognition of PH1 in neonates presenting with severe systemic symptoms.
- Prompt and aggressive management can potentially mitigate severe neurological and renal sequelae.
- Further research into optimal treatment strategies for neonatal PH1 is warranted.